Robot arm takes on first appendix surgery in humans
NCT ID NCT07455487
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early study tests a new robotic surgical system (Revolve) in 3 adults with simple appendicitis who are already scheduled for appendix removal. The robot helps the surgeon work more precisely during minimally invasive surgery. The main goal is to see if the device can safely complete the surgery without needing to switch to standard methods.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 3 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Apr 2026
An estimate. Start dates often move.
- Expected to finish
-
Jan 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 to 40 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Inpatients at Unity Health Toronto - St. Michael's Hospital scheduled for an elective appendectomy * Ages of 21-40 years old * Male and non-pregnant female patients (pregnancy test required) * No co-morbidities * Body Mass Index (BMI) between 18.5 and 25kg/m2 * On no medications * Not taking any recreational drugs * Uncomplicated acute appendicitis (confirmed through abdominal ultrasound or abdominal computed tomography (CT) scan) * The pre-operative white blood cell count (WBC) must be between 4,500 - 15,000 cells per microliter. Exclusion Criteria: * Any patient who does not have all the inclusion criteria described above. * Imaging of perforated appendix, free air, phlegmon, abscess, fluid collection, other any abdominal disease. * Any other abnormal laboratory test performed pre-operatively will cause the exclusion of the patient from the study.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Appendicitis acute are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Two simple tweaks may cut pain after appendix surgery
- Can less dye and less radiation still spot appendicitis?
- A new lens on children's surgery: can video grading predict recovery?
- To cut or not to cut: a trial questions routine appendectomy for normal appendices
- Simple pressure check may spare kids from post-surgery sore throat
- New blood test could spot hidden belly infections faster